Johnson & Johnson kickback case is back on
Compliance Monitor, August 19, 2009
A federal appeals court revived the kickback portion of the case against Johnson & Johnson, according to an article in the Boston Globe. The portion of the case will be heard in the U.S. District Court Boston—the same court that originally dismissed the case.
Two former Johnson & Johnson sales people filed a whistleblower alleging that the company’s Ortho Biotech Products division paid doctors, in the form of free Procrit, honoraria, and other monetary inducements, to prescribe Procrit.
According to the article, Procrit is among Johnson & Johnson’s most lucrative products, bringing in approximately $2.5 billion last year.
Related Products
Most Popular
- Articles
-
- Note from Hugh
- Q/A: How should we report irradiated blood products?
- 2014 SNF Proposed Rule Analysis: Revising and rebasing the SNF market basket
- Reminder: MDS correction policy to be updated effective May 19
- Ask the expert: BIMS assessment
- CMS issues transmittal to update the Medicare Provider Reimbursement Manual
- CMS corrects edit 84, deletes modifiers
- Residents say cause of death reporting often inaccurate
- Creative Ways to Trim Nurse Staffing Costs
- CMS looking for comments on molecular pathology payments
- E-mailed
-
- Georgia hospitals scrambling to create residency positions
- Q/A: How should we report irradiated blood products?
- CMS looking for comments on molecular pathology payments
- Tip of the week: Build a successful website to impress candidates
- Joint Commission seeks input on behavioral health home certification
- Applying multiple procedure payment reductions to therapy cap amounts for Critical Access Hospital (CAH) claims
- Don't burn those ICD-9-CM Manuals just yet
- HCA initiative boosts flu shots among hospital workers
- Tip: Keep an eye on evolving molecular pathology codes
- Depressing Leapfrog scores haunt hospitals
- Searched
